Literature DB >> 24944802

Maintenance of chaperone-mediated autophagy activity in cultured cells expressing mutant huntingtin.

Xiang Li1, Jianbin Wang2.   

Abstract

Huntington's disease (HD) is an autosomal dominant neurodegenerative disease caused by mutant huntingtin (Htt) with an expanded polyglutamine tract. It has been reported that Htt regulates autophagy. However, it remains unclear whether mutant Htt affects chaperone-mediated autophagy (CMA). Our study aimed to investigate the effect of mutant Htt on CMA activity in cultured HEK293T cells. A HEK293T cell model of HD was produced by transient transfection of wild-type (20Q) or mutant (120Q) Htt plasmids. The effect of mutant Htt on two CMA components, lysosomal-associated membrane protein 2a (Lamp2a) and heat-shock cognate protein 70 (Hsc70), was determined by western blotting and immunofluorescent staining. We observed that mutant Htt did not significantly alter the expression of Lamp2a and Hsc70 when compared to normal Htt. These findings suggest that mutant Htt does not reduce CMA activity and that enhancing CMA activity to clear mutant Htt may be a novel strategy for the management of HD.

Entities:  

Keywords:  Huntington’s disease; chaperone-mediated autophagy; heat-shock cognate protein 70; lysosomal-associated membrane protein 2a

Year:  2014        PMID: 24944802      PMCID: PMC4051467          DOI: 10.3892/br.2014.278

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  23 in total

1.  Regulation of lamp2a levels in the lysosomal membrane.

Authors:  A M Cuervo; J F Dice
Journal:  Traffic       Date:  2000-07       Impact factor: 6.215

Review 2.  Chaperone-mediated autophagy: machinery, regulation and biological consequences.

Authors:  Wenming Li; Qian Yang; Zixu Mao
Journal:  Cell Mol Life Sci       Date:  2010-10-26       Impact factor: 9.261

Review 3.  The molecular biology of Huntington's disease.

Authors:  L W Ho; J Carmichael; J Swartz; A Wyttenbach; J Rankin; D C Rubinsztein
Journal:  Psychol Med       Date:  2001-01       Impact factor: 7.723

4.  Progressive depletion of complexin II in a transgenic mouse model of Huntington's disease.

Authors:  A J Morton; J M Edwardson
Journal:  J Neurochem       Date:  2001-01       Impact factor: 5.372

5.  Constitutive upregulation of chaperone-mediated autophagy in Huntington's disease.

Authors:  Hiroshi Koga; Marta Martinez-Vicente; Esperanza Arias; Susmita Kaushik; David Sulzer; Ana Maria Cuervo
Journal:  J Neurosci       Date:  2011-12-14       Impact factor: 6.167

6.  Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules.

Authors:  Laurent R Gauthier; Bénédicte C Charrin; Maria Borrell-Pagès; Jim P Dompierre; Hélène Rangone; Fabrice P Cordelières; Jan De Mey; Marcy E MacDonald; Volkmar Lessmann; Sandrine Humbert; Frédéric Saudou
Journal:  Cell       Date:  2004-07-09       Impact factor: 41.582

Review 7.  Intracellular degradation of misfolded proteins in polyglutamine neurodegenerative diseases.

Authors:  Xiang Li; He Li; Xiao-Jiang Li
Journal:  Brain Res Rev       Date:  2008-08-23

8.  Activation of a selective pathway of lysosomal proteolysis in rat liver by prolonged starvation.

Authors:  A M Cuervo; E Knecht; S R Terlecky; J F Dice
Journal:  Am J Physiol       Date:  1995-11

9.  Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein.

Authors:  Sovan Sarkar; Janet E Davies; Zebo Huang; Alan Tunnacliffe; David C Rubinsztein
Journal:  J Biol Chem       Date:  2006-12-20       Impact factor: 5.157

10.  Small molecules enhance autophagy and reduce toxicity in Huntington's disease models.

Authors:  Sovan Sarkar; Ethan O Perlstein; Sara Imarisio; Sandra Pineau; Axelle Cordenier; Rebecca L Maglathlin; John A Webster; Timothy A Lewis; Cahir J O'Kane; Stuart L Schreiber; David C Rubinsztein
Journal:  Nat Chem Biol       Date:  2007-05-07       Impact factor: 15.040

View more
  1 in total

1.  Chaperone-mediated autophagy and disease: Implications for cancer and neurodegeneration.

Authors:  Raquel Gómez-Sintes; Esperanza Arias
Journal:  Mol Aspects Med       Date:  2021-10-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.